Embolización transarterial de hepatocarcinoma como terapia down-staging en la realización de trasplante

Liver transplantation is one of the definitive treatments for hepatocellular carcinoma (HCC). The criteria of Milan and UCSF are best used for eligibility of a candidate for transplant with HCC. Currently, patients who exceed the established crite- ria, the bridge therapy is proposed by using adjuvant therapies such as chemoembolization and transarterial tumor emboliza- tion to reduce the size of the lesion, known as down staging. We describe a patient with a single 5.8 cm tumor who received a soft embolization as down-staging therapy, and after two months received a liver transplant. After 18 months, the pa- tient is alive without recurrence of the tumor. The usefulness of transarterial embolization as down staging therapy in a pa- tient with hepatocellular carcinoma is demonstrated.